eanNews
  • EAN News
    • All President’s Corner Executive Page EAN News EAN Congress news Interviews
      Research Highlights

      Research Highlights of the Month – August 2025

      August 12, 2025

      Executive Page

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      President’s Corner

      President’s Corner – August 2025

      August 12, 2025

      Paper of the Month

      Research Paper of the Month: Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease

      August 12, 2025

      President’s Corner

      President’s Corner – August 2025

      August 12, 2025

      President’s Corner

      President’s Corner – July 2025

      July 16, 2025

      President’s Corner

      President’s Corner – June 2025

      June 3, 2025

      President’s Corner

      President’s Corner – May 2025

      May 7, 2025

      Executive Page

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      Executive Page

      Executive Page: thank you for making the EAN Congress 2025 a great success!

      July 16, 2025

      Executive Page

      Executive Page: Get ready for EAN 2025 in Helsinki!

      June 3, 2025

      Executive Page

      Executive Page: panels, guidelines, EBRAINS, and more ways to get involved in EAN scientific activities

      May 7, 2025

      EAN News

      Research Highlights of the Month – August 2025

      August 12, 2025

      EAN News

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      EAN News

      President’s Corner – August 2025

      August 12, 2025

      EAN News

      Research Paper of the Month: Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease

      August 12, 2025

      EAN Congress news

      Revisit the Highlights of EAN 2025 in Our Congress Review eBook

      July 24, 2025

      EAN Congress news

      EAN 2025 Career development Session on AI: Is artificial intelligence coming to steal your job?

      July 16, 2025

      EAN Congress news

      Executive Page: thank you for making the EAN Congress 2025 a great success!

      July 16, 2025

      EAN Congress news

      First 20 EAN Leadership Programme participants graduate, as second group gets underway

      July 10, 2025

      Interviews

      Video Interview: Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease, with Raphael Wurm

      March 14, 2025

      Interviews

      Video Interview: EMA approval of lecanemab, with Sebastiaan Engelborghs, EAN Dementia Panel Co-Chair

      January 15, 2025

      Interviews

      Video interview: Claudia Sommer, incoming Editor-in-Chief of the European Journal of Neurology

      January 3, 2025

      Interviews

      Video interviews: meet some of the EAN’s national neurological society partners!

      November 20, 2024

  • Research
    • All Research Funding Paper of the Month Research Highlights
      Research

      EMA Neurology News – August 2025

      August 20, 2025

      Research Highlights

      Research Highlights of the Month – August 2025

      August 12, 2025

      Paper of the Month

      Research Paper of the Month: Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease

      August 12, 2025

      Research

      EMA Neurology News – July 2025

      July 24, 2025

      Research Funding

      Draft Innovative Health Initiative (IHI) Funding Call topics related to the brain

      May 2, 2025

      Research Funding 'Horizon Europe' in large 3D text, surrounded by illustrations of people undertaking various activities

      Upcoming Horizon Europe Funding Opportunities for Neurology Researchers (Draft Calls)

      May 2, 2025

      Paper of the Month

      Research Paper of the Month: Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease

      August 12, 2025

      Paper of the Month

      Research Paper of the Month: Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation (CATALYST)

      July 16, 2025

      Paper of the Month

      Research Papers of the Month: Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease / Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease

      June 2, 2025

      Paper of the Month

      Research Papers of the Month: Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis / Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis

      May 7, 2025

      Research Highlights

      Research Highlights of the Month – August 2025

      August 12, 2025

      Research Highlights

      Research Highlights of the Month – July 2025

      July 16, 2025

      Research Highlights

      Research Highlights of the Month – June 2025

      June 11, 2025

      Research Highlights

      Research Highlights of the Month – May 2025

      May 13, 2025

  • Education
    • All Mid-Career eLearning Student Corner Resident and Research Fellows Fellowship reports
      Mid-Career

      Certificate of Advanced Studies (CAS) in Brain Health starts second round in January 2026

      August 25, 2025

      eLearning

      Join our Webinar on Multidisciplinary Perspectives on aTTR Amyloidosis: From Nerves to Heart

      August 21, 2025

      Resident and Research Fellows

      Sign up for the 5th EAN Science School, 13-17 March, 2026

      August 20, 2025

      Resident and Research Fellows

      EAN Regional Teaching Day in Riga, Latvia – 6 November 2025

      August 13, 2025

      Mid-Career

      Certificate of Advanced Studies (CAS) in Brain Health starts second round in January 2026

      August 25, 2025

      Mid-Career

      First 20 EAN Leadership Programme participants graduate, as second group gets underway

      July 10, 2025

      Mid-Career

      Empowering growth: my journey through the EAN Leadership Programme

      March 14, 2025

      Mid-Career

      Video: EAN Advocacy Training Ambassadors share their inspiring journeys

      November 22, 2024

      eLearning

      Join our Webinar on Multidisciplinary Perspectives on aTTR Amyloidosis: From Nerves to Heart

      August 21, 2025

      eLearning

      Call for Applications: eanCampus Associate Editors

      July 1, 2025

      eLearning

      Brush up on the EAN 2025 Overarching Theme on the eanCampus!

      June 10, 2025

      eLearning Cartoon image of a desk with computer screen, lamp and office chair

      Continue learning with brand new content on the eanCampus!

      June 10, 2025

      Student Corner

      Student Teaser Fellowships winners 2025

      June 6, 2025

      Student Corner Photo of a sheet of paper, pencil and crumpled paper on a desk.

      Why Neurology? Read some compelling answers from our EAN 2025 essay contest winners!

      May 12, 2025

      Student Corner

      Student Teaser Fellowship reports 2023 – Paris & Basel

      March 12, 2025

      Student Corner

      Apply now for the Student Teaser Fellowship 2025!

      February 1, 2025

      Resident and Research Fellows

      Sign up for the 5th EAN Science School, 13-17 March, 2026

      August 20, 2025

      Resident and Research Fellows

      EAN Regional Teaching Day in Riga, Latvia – 6 November 2025

      August 13, 2025

      Resident and Research Fellows

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      Resident and Research Fellows

      RRFS Highlights at the 11th EAN Congress 2025 in Helsinki

      August 5, 2025

      Fellowship reports

      Research Fellowship Reports 2023: Lyon, Berlin, & London

      March 31, 2025

      Fellowship reports

      Student Teaser Fellowship reports 2023 – Paris & Basel

      March 12, 2025

      Fellowship reports

      Clinical Fellowship Reports 2023: Utrecht, Dianalund, & London

      February 20, 2025

      Fellowship reports

      Research Fellowship Reports 2023: London & Vienna/Paris

      October 8, 2024

  • Other News
    • All EAN Staff EBC News in general Surveys
      Advocacy

      Why do Placebo and Nocebo Effects Matter? – Improving the Education of Healthcare Professionals | 5 November 2025

      August 21, 2025

      Other News

      EAN Panel Management Group Member Discusses Palliative Care on OneNeurology Podcast Marking World Brain Day

      August 8, 2025

      Other News

      Empowering the HD Community: The Launch of the Huntington Academy

      July 10, 2025

      Brain Health

      EAN TV | National Brain Plans and the Path Toward EU Coordination: Insights from Finland and Europe

      June 21, 2025

      EAN Staff

      EAN Head Office Profiles: Ulla & Piyapat

      December 1, 2023

      EAN Staff

      EAN Head Office Profiles: Kathrin & Sasha

      August 28, 2023

      EAN Staff Anja Sander receiving flowers at the end of EAN Congress 2023

      Celebrating 20 Years of Excellence: Anja Sander, EAN’s Executive Director!

      August 3, 2023

      EAN Staff

      EAN Head Office Profiles: Dauren & Benita

      June 5, 2023

      EBC

      EAN TV | National Brain Plans and the Path Toward EU Coordination: Insights from Finland and Europe

      June 21, 2025

      EBC

      EAN TV | European Brain Council: Paving the Way for a European Brain Health Partnership

      June 21, 2025

      EBC Composite image containing various photos from European Brain Council events, plus the EBC logo

      EBC launches 2024 annual report

      April 25, 2025

      EBC

      Brain Innovation Days announces theme and subtheme for 2025 edition!

      March 29, 2025

      News in general

      New paper offers insight into patient involvement in neurological research 

      January 31, 2025

      News in general

      Join the European Brain Council’s ‘Towards a Rare Brain Disease Ecosystem’ event in Brussels on 20 February!

      January 31, 2025

      News in general

      The Brain Prize 2024: Pioneering work in computational and theoretical neuroscience is awarded the world’s largest brain research prize

      March 5, 2024

      News in general

      WHO’s Intersectoral Global Action Plan on epilepsy and other neurological disorders (IGAP) published in all six UN languages

      August 3, 2023

      Surveys

      Public Consultation – European Charter for the Responsible Development of Neurotechnologies

      November 25, 2024

      Surveys

      A survey on connectomics: key insights from EAN neurologists

      July 25, 2024

      Surveys

      Survey: Mapping European Neurological Programs in Solid Organ Transplant Centers

      May 31, 2024

      Surveys

      Neurorehabilitation Across Europe after Ischemic and Traumatic Brain Injuries: a survey to increase knowledge on brain-injury-specific neurorehabilitation

      July 14, 2023

  • EAN
  • Congress 2025
  • eanNews
  • eanCampus
  • Eur J Neurol
  • Brain Health Mission

eanNews

  • EAN News
    • All President’s Corner Executive Page EAN News EAN Congress news Interviews
      Research Highlights

      Research Highlights of the Month – August 2025

      August 12, 2025

      Executive Page

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      President’s Corner

      President’s Corner – August 2025

      August 12, 2025

      Paper of the Month

      Research Paper of the Month: Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease

      August 12, 2025

      President’s Corner

      President’s Corner – August 2025

      August 12, 2025

      President’s Corner

      President’s Corner – July 2025

      July 16, 2025

      President’s Corner

      President’s Corner – June 2025

      June 3, 2025

      President’s Corner

      President’s Corner – May 2025

      May 7, 2025

      Executive Page

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      Executive Page

      Executive Page: thank you for making the EAN Congress 2025 a great success!

      July 16, 2025

      Executive Page

      Executive Page: Get ready for EAN 2025 in Helsinki!

      June 3, 2025

      Executive Page

      Executive Page: panels, guidelines, EBRAINS, and more ways to get involved in EAN scientific activities

      May 7, 2025

      EAN News

      Research Highlights of the Month – August 2025

      August 12, 2025

      EAN News

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      EAN News

      President’s Corner – August 2025

      August 12, 2025

      EAN News

      Research Paper of the Month: Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease

      August 12, 2025

      EAN Congress news

      Revisit the Highlights of EAN 2025 in Our Congress Review eBook

      July 24, 2025

      EAN Congress news

      EAN 2025 Career development Session on AI: Is artificial intelligence coming to steal your job?

      July 16, 2025

      EAN Congress news

      Executive Page: thank you for making the EAN Congress 2025 a great success!

      July 16, 2025

      EAN Congress news

      First 20 EAN Leadership Programme participants graduate, as second group gets underway

      July 10, 2025

      Interviews

      Video Interview: Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease, with Raphael Wurm

      March 14, 2025

      Interviews

      Video Interview: EMA approval of lecanemab, with Sebastiaan Engelborghs, EAN Dementia Panel Co-Chair

      January 15, 2025

      Interviews

      Video interview: Claudia Sommer, incoming Editor-in-Chief of the European Journal of Neurology

      January 3, 2025

      Interviews

      Video interviews: meet some of the EAN’s national neurological society partners!

      November 20, 2024

  • Research
    • All Research Funding Paper of the Month Research Highlights
      Research

      EMA Neurology News – August 2025

      August 20, 2025

      Research Highlights

      Research Highlights of the Month – August 2025

      August 12, 2025

      Paper of the Month

      Research Paper of the Month: Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease

      August 12, 2025

      Research

      EMA Neurology News – July 2025

      July 24, 2025

      Research Funding

      Draft Innovative Health Initiative (IHI) Funding Call topics related to the brain

      May 2, 2025

      Research Funding 'Horizon Europe' in large 3D text, surrounded by illustrations of people undertaking various activities

      Upcoming Horizon Europe Funding Opportunities for Neurology Researchers (Draft Calls)

      May 2, 2025

      Paper of the Month

      Research Paper of the Month: Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease

      August 12, 2025

      Paper of the Month

      Research Paper of the Month: Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation (CATALYST)

      July 16, 2025

      Paper of the Month

      Research Papers of the Month: Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease / Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease

      June 2, 2025

      Paper of the Month

      Research Papers of the Month: Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis / Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis

      May 7, 2025

      Research Highlights

      Research Highlights of the Month – August 2025

      August 12, 2025

      Research Highlights

      Research Highlights of the Month – July 2025

      July 16, 2025

      Research Highlights

      Research Highlights of the Month – June 2025

      June 11, 2025

      Research Highlights

      Research Highlights of the Month – May 2025

      May 13, 2025

  • Education
    • All Mid-Career eLearning Student Corner Resident and Research Fellows Fellowship reports
      Mid-Career

      Certificate of Advanced Studies (CAS) in Brain Health starts second round in January 2026

      August 25, 2025

      eLearning

      Join our Webinar on Multidisciplinary Perspectives on aTTR Amyloidosis: From Nerves to Heart

      August 21, 2025

      Resident and Research Fellows

      Sign up for the 5th EAN Science School, 13-17 March, 2026

      August 20, 2025

      Resident and Research Fellows

      EAN Regional Teaching Day in Riga, Latvia – 6 November 2025

      August 13, 2025

      Mid-Career

      Certificate of Advanced Studies (CAS) in Brain Health starts second round in January 2026

      August 25, 2025

      Mid-Career

      First 20 EAN Leadership Programme participants graduate, as second group gets underway

      July 10, 2025

      Mid-Career

      Empowering growth: my journey through the EAN Leadership Programme

      March 14, 2025

      Mid-Career

      Video: EAN Advocacy Training Ambassadors share their inspiring journeys

      November 22, 2024

      eLearning

      Join our Webinar on Multidisciplinary Perspectives on aTTR Amyloidosis: From Nerves to Heart

      August 21, 2025

      eLearning

      Call for Applications: eanCampus Associate Editors

      July 1, 2025

      eLearning

      Brush up on the EAN 2025 Overarching Theme on the eanCampus!

      June 10, 2025

      eLearning Cartoon image of a desk with computer screen, lamp and office chair

      Continue learning with brand new content on the eanCampus!

      June 10, 2025

      Student Corner

      Student Teaser Fellowships winners 2025

      June 6, 2025

      Student Corner Photo of a sheet of paper, pencil and crumpled paper on a desk.

      Why Neurology? Read some compelling answers from our EAN 2025 essay contest winners!

      May 12, 2025

      Student Corner

      Student Teaser Fellowship reports 2023 – Paris & Basel

      March 12, 2025

      Student Corner

      Apply now for the Student Teaser Fellowship 2025!

      February 1, 2025

      Resident and Research Fellows

      Sign up for the 5th EAN Science School, 13-17 March, 2026

      August 20, 2025

      Resident and Research Fellows

      EAN Regional Teaching Day in Riga, Latvia – 6 November 2025

      August 13, 2025

      Resident and Research Fellows

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      Resident and Research Fellows

      RRFS Highlights at the 11th EAN Congress 2025 in Helsinki

      August 5, 2025

      Fellowship reports

      Research Fellowship Reports 2023: Lyon, Berlin, & London

      March 31, 2025

      Fellowship reports

      Student Teaser Fellowship reports 2023 – Paris & Basel

      March 12, 2025

      Fellowship reports

      Clinical Fellowship Reports 2023: Utrecht, Dianalund, & London

      February 20, 2025

      Fellowship reports

      Research Fellowship Reports 2023: London & Vienna/Paris

      October 8, 2024

  • Other News
    • All EAN Staff EBC News in general Surveys
      Advocacy

      Why do Placebo and Nocebo Effects Matter? – Improving the Education of Healthcare Professionals | 5 November 2025

      August 21, 2025

      Other News

      EAN Panel Management Group Member Discusses Palliative Care on OneNeurology Podcast Marking World Brain Day

      August 8, 2025

      Other News

      Empowering the HD Community: The Launch of the Huntington Academy

      July 10, 2025

      Brain Health

      EAN TV | National Brain Plans and the Path Toward EU Coordination: Insights from Finland and Europe

      June 21, 2025

      EAN Staff

      EAN Head Office Profiles: Ulla & Piyapat

      December 1, 2023

      EAN Staff

      EAN Head Office Profiles: Kathrin & Sasha

      August 28, 2023

      EAN Staff Anja Sander receiving flowers at the end of EAN Congress 2023

      Celebrating 20 Years of Excellence: Anja Sander, EAN’s Executive Director!

      August 3, 2023

      EAN Staff

      EAN Head Office Profiles: Dauren & Benita

      June 5, 2023

      EBC

      EAN TV | National Brain Plans and the Path Toward EU Coordination: Insights from Finland and Europe

      June 21, 2025

      EBC

      EAN TV | European Brain Council: Paving the Way for a European Brain Health Partnership

      June 21, 2025

      EBC Composite image containing various photos from European Brain Council events, plus the EBC logo

      EBC launches 2024 annual report

      April 25, 2025

      EBC

      Brain Innovation Days announces theme and subtheme for 2025 edition!

      March 29, 2025

      News in general

      New paper offers insight into patient involvement in neurological research 

      January 31, 2025

      News in general

      Join the European Brain Council’s ‘Towards a Rare Brain Disease Ecosystem’ event in Brussels on 20 February!

      January 31, 2025

      News in general

      The Brain Prize 2024: Pioneering work in computational and theoretical neuroscience is awarded the world’s largest brain research prize

      March 5, 2024

      News in general

      WHO’s Intersectoral Global Action Plan on epilepsy and other neurological disorders (IGAP) published in all six UN languages

      August 3, 2023

      Surveys

      Public Consultation – European Charter for the Responsible Development of Neurotechnologies

      November 25, 2024

      Surveys

      A survey on connectomics: key insights from EAN neurologists

      July 25, 2024

      Surveys

      Survey: Mapping European Neurological Programs in Solid Organ Transplant Centers

      May 31, 2024

      Surveys

      Neurorehabilitation Across Europe after Ischemic and Traumatic Brain Injuries: a survey to increase knowledge on brain-injury-specific neurorehabilitation

      July 14, 2023

Paper of the MonthEAN NewsFeatured Slider

Paper of the month: Apomorphine pump is effective for motor fluctuations in Parkinson’s disease

September 1, 2018

by Thomas M. Jenkins

 

For September 2018, we have selected:  Katzenschlager R, Poewe W, Rascol O, et al. Apomorphine subcutaneous infusion in patients with Parkinson’s disease with persisten motor fluctuations (TOLEDO): a multicenter, double-blind, randomized, placebo-controlled trial. Lancet Neurol July 25, 2018. doi:10.1016/S1474-4422(18)30284-4.

 

Subcutaneous infusion of apomorphine, a potent dopamine receptor agonist, is widely used in patients with Parkinson’s disease (PD) with motor fluctuations not optimally controlled with oral medication, but the previous evidence base to support this approach was weak, derived from open label studies.

Our paper of the month reports the first randomized placebo-controlled trial of subcutaneous apomorphine in PD. This phase III “TOLEDO” trial was positive, establishing an evidence base for current clinical practice.

 

The lead investigators are based in Vienna and patients were recruited from 23 European hospitals. Inclusion criteria were age >30 years, idiopathic PD diagnosed for at least 3 years, based on modified Queen Square Brain Bank criteria, with motor fluctuations not adequately controlled on optimal conventional medical treatment, defined as four or more daily doses of levodopa, and as individually assessed by the investigators. Patients had to fulfill Hoehn and Yahr stage 3 or less when “on”, and 2-5 when “off”. No changes to usual medication were allowed for four weeks prior to study entry, and patient ability to accurately document symptoms in their diaries was assessed. A mean of more than three hours “off’ time/day and no days with fewer than two hours “off” time was required to be eligible for study entry  Exclusion criteria included previous surgical treatment for PD, previous use of apomorphine, recent treatment with intrajejunal levodopa, falls due to severe freezing, or significant postural instability during “on” time,  mini-mental state examination less than 25/30, recent psychosis of at least moderate severity within the previous year (mild visual hallucinations with preserved insight were allowed), or prolonged QT interval.

 

Patients were randomly allocated to apomorphine or placebo saline infusion, and initiated as inpatients, for up to 18 hours a day, for 12 weeks. Domperidone was given concurrently as necessary. It was allowed to adjust flow rates during the first four weeks, as well as other oral medications, according to individual patient response, but all study participants and investigators were masked to assigned treatment. No further changes in apomorphine dose were allowed for the remaining eight weeks in the study. Limited rescue doses of levodopa were allowed. The primary outcome measure was the absolute change in “off” time, between baseline and 12 weeks, documented from patient diaries. Secondary outcomes included changes in on-time without troublesome dyskinesia, change in levodopa-equivalent medication dose, UPDRS motor examination scores and the PDQ-8 quality of life measure. Patients with efficacy data for any time-point were included in the analysis. Missing data for the primary endpoint were imputed using a last observation carried forward approach. Wilcoxon rank sum tests were used to compare treatment groups.

 

Data from 106 patients were analyzed, 53 treated with apomorphine, and 53 with placebo, of whom 71 patients completed the full 12 weeks treatment. Apomorphine at a mean dose of 4.7 mg/hour was found to reduce “off” time by 1.9 hours/day compared with placebo (95% CI -0.6 to -3.2 hours/day, p=0.0025). Common side effects were skin reactions, nausea and somnolence. Six patients in the apomorphine group withdrew due to side effects (one severe hypotension, one leukopenia/anemia, one visual hallucinations, one gait disturbance, one skin reaction, one (unrelated) myocardial infarction. There was no change in UPDRS motor scores or PDQ-8 quality of life measures, but the apomorphine group achieved more “on” time without troublesome dyskinesias and greater reductions in levodopa-equivalent medication doses. The authors concluded that subcutaneous apomorphine provides clinically meaningful benefits in “off” time in PD. A 12 month open-label extension study is now being performed.

 

“This study represents an important step in establishing optimal treatment regimes for patients with more advanced PD who no longer fully respond to oral treatment”, said Professor Philippe Damier, Department of Neurology, University of Nantes, France. “Whilst a limitation inherent in testing apomorphine is that it is difficult to fully blind participants and assessors, and an imputational statistical approach had to be used because of cohort drop-out rates, overall the rigorous trial methodology provides the best class evidence to date for the benefits of apomorphine, and the positive treatment effect appears meaningful and concordant with clinical experience.”

 

“This could now pave the way for future trials comparing the different advanced therapies, for example subcutaneous apomorphine and intra-jejunal approaches”, said the leading author of the paper, Pr. Regina Katzenschlager, Department of Neurology, Danube Hospital Vienna, Austria, “and help optimize management for individuals with PD who are no longer responding to oral treatment.”

 

The other nominees for the September 2018 Paper of the month are:

 

  • Rothwell PM, Cook NR, Gaziano JM, et al. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patients’ data from randomized trials. Lancet Neurol July 12, 2018; doi.org/10.1016/S0140-6736(18)31133-4. In this study, the authors analyzed the effects of different doses of aspirin according to body weight and dose in the long-term primary prevention of cardiovascular events and cancer, stratifying patients by age and sex. As main findings, ≤100 mg aspirin was effective only in patients weighting ≤70 kg, whereas ≥300 mg aspirin were effective only in patients weighting ≥70 Kg. Further research about aspirin dose and bodyweight interaction is clearly needed.

 

  • Ludolph AC, Schuster J, Dorst J, et al., on behalf of the RAS-ALS Study. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized, double-blind, parallel-group, placebo-controlled, phase 2 trial. Lancet Neurol June 19, 2018; doi.org/10.1016/S1474-4422(18)30176-5. In this German phase II randomized, double-blind, placebo-controlled trial, 1mg rasagiline was studied in 273 patients with possible, probable or definite amyotrophic lateral sclerosis (ALS). At 18 months, no differences between rasagiline and placebo was found related to survival time. Post-hoc analysis suggested that rasagiline could have modifying disease effect in those patients with initial slope of ALS Functional Rating Scale Revised greater than 0.5 per month at baseline.

 

  • Hughes R, Dalakas MC, Merkies I, et al. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicenter, randomized controlled trial. Lancet Neurol July 9, 2018; doi.org/10.1016/S1474-4422(18)30202-3. The efficacy of 0.5 mg fingolimod in delaying disability progression in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) was evaluated in 106 patients from 48 neurology centers worldwide. The trial ended for futility after 44 confirmed worsening events.

 

 

 

Paper of the month: Apomorphine pump is effective for motor fluctuations in Parkinson’s disease was last modified: November 13th, 2018 by Editor
Share this...
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
Linkedin
apomorphinedomperidoneUPDRSPDQ-8Parkinson's diseaselevodopa
previous post
13th international Summer School of Neurology
next post
Country of the month – Azerbaijan

You may also like

Executive Page: the RRFS is here to support you – and help shape the future of European neurology

August 12, 2025

President’s Corner – August 2025

August 12, 2025

Research Paper of the Month: Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease

August 12, 2025

Executive Page: thank you for making the EAN Congress 2025 a great success!

July 16, 2025

President’s Corner – July 2025

July 16, 2025

Research Paper of the Month: Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation (CATALYST)

July 16, 2025

EAN 2025 Presidential Symposium: bridging neuroscience frontiers from theory to clinical impact

June 22, 2025

Team International takes the win at the EAN 2025 BrainChallenge

June 22, 2025

EAN 2025 Opening Session kicks off with visionary roadmap for the future of European neurology

June 22, 2025

Watch now! EAN 2025 Opening Session – full recording!

June 21, 2025

Leave a Comment Cancel Reply

You need to be logged in to comment. Please login to MyEAN on top.

Upcoming Events

Jul
24
Thu
all-day INUS – Medsynergy Summer Course ...
INUS – Medsynergy Summer Course ...
Jul 24 – Aug 28 all-day
  This international online lecture series offers a structured introduction to neuro-urology, combining foundational science, clinical practice, and research insights. Led by globally recognized INUS faculty and pioneers in the…
Sep
4
Thu
all-day 9th International Congress on Ne...
9th International Congress on Ne...
Sep 4 – Sep 6 all-day
9th International Congress on Neuropathic Pain - NeuPSIG 2025
  9th International Congress on Neuropathic Pain will take place in September 2025 in Berlin, Germany. NeuPSIG’s mission is to advance the understanding of mechanisms, assessment, prevention, and treatment of…
Sep
5
Fri
all-day Hydrocephalus 2025 World Congress
Hydrocephalus 2025 World Congress
Sep 5 – Sep 8 all-day
Hydrocephalus 2025 World Congress
  The Hydrocephalus 2025 World Congress will be held from September 5 to September 8, 2025, in Toulouse. The continued growth of the Hydrocephalus Annual Congress highlights its high quality…
Sep
9
Tue
all-day 17th World Congress of Biologica...
17th World Congress of Biologica...
Sep 9 – Sep 12 all-day
17th World Congress of Biological Psychiatry
  Join leading researchers, clinicians, and professionals from around the globe for the 17th World Congress of Biological Psychiatry, hosted by the World Federation of Societies of Biological Psychiatry (WFSBP).…
Sep
10
Wed
all-day International Headache Congress ...
International Headache Congress ...
Sep 10 – Sep 13 all-day
International Headache Congress 2025
  IHC 2025 will bring together international colleagues in the headache field to share knowledge and learn about the latest advances in headache diagnosis and treatment. We are delighted to hold…
View Calendar

Keep in touch

Facebook Instagram Linkedin
EAN Pages is a members service of the European Academy of Neurology https://www.ean.org

All content from January 2012 - June 2013 was published by EFNS; content from July 2013 - June 2014 by EFNS and ENS.

ISSN 2310-2934

Keep in touch

Facebook Twitter Instagram Linkedin

Archives

Pages

  • Privacy Policy
  • About us
  • Help

Back To Top